Glucotrack (GCTK) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Glucotrack (GCTK) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 13.85% |
| 10 | Glucotrack | 1.06 Mn | -68,752.73 | - | 93.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.00% |
| Dec 31, 2025 | 99.20% |
| Sep 30, 2025 | 99.32% |
| Jun 30, 2025 | 99.02% |
| Mar 31, 2025 | 97.09% |
| Dec 31, 2024 | -200.57% |
| Sep 30, 2024 | -220.57% |
| Jun 30, 2024 | -274.57% |
| Mar 31, 2024 | -42.71% |
| Dec 31, 2023 | 39.55% |
| Sep 30, 2023 | 61.58% |
| Jun 30, 2023 | 29.15% |
| Mar 31, 2023 | -17.47% |
| Dec 31, 2022 | 185.57% |
| Sep 30, 2022 | 220.99% |
| Jun 30, 2022 | 229.10% |
| Mar 31, 2022 | -21.99% |
| Dec 31, 2021 | -67.31% |
| Sep 30, 2021 | 14.03% |
| Jun 30, 2021 | -42.05% |